Mckesson Packaging Services BuPROPion HCL Tablets Recall

Why it was recalled

Failed Moisture Limits: Product tested out-of-specification for moisture content.

Product description

BuPROPion HCL Tablets, USP, 75 mg, packaged as UD 100 tablets (10x10), Rx Only, Mfg by: Sandoz Inc., 508 Carnegie Center, Suite 400, Princeton, NJ 08805, NDC: 63739-706-10

Lot numbers, UPCs & expiration codes

Lot # 0113148, 0113149, 0113150, Exp: 04/18; 0113636, Exp: 06/18; 0114513, Exp: 10/18

Where it was sold

Nationwide in the US

What to do if you have this product

Compare the lot number and expiration date on your package with the codes above.
Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
If you have symptoms you think are related, contact your doctor. In an emergency call 911.
Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number: D-0928-2017
Classification: Class III
Status: Terminated
Recall initiated: May 30, 2017
FDA report date: Jul 5, 2017
Quantity: 942 cartons
Recall type: Voluntary: Firm initiated
Recalling firm: Mckesson Packaging Services

Original FDA data

Every field from FDA enforcement report D-0928-2017, exactly as published.

Show all FDA fields

City: Concord
State: NC
Status: Terminated
Country: United States
Event ID: 77411
Address: 7101 Weddington Rd NW
Code information: Lot # 0113148, 0113149, 0113150, Exp: 04/18; 0113636, Exp: 06/18; 0114513, Exp: 10/18
Postal code: 28027-3412
Report date: Jul 5, 2017
Product type: Drugs
Recall number: D-0928-2017
Classification: Class III
Recalling firm: Mckesson Packaging Services
Product quantity: 942 cartons
Termination date: Feb 6, 2020
Reason for recall: Failed Moisture Limits: Product tested out-of-specification for moisture content.
Voluntary / mandated: Voluntary: Firm initiated
Product description: BuPROPion HCL Tablets, USP, 75 mg, packaged as UD 100 tablets (10x10), Rx Only, Mfg by: Sandoz Inc., 508 Carnegie Center, Suite 400, Princeton, NJ 08805, NDC: 63739-706-10
Distribution pattern: Nationwide in the US
Recall initiation date: May 30, 2017
Initial firm notification: Letter
Center classification date: Jun 29, 2017

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-0928-2017, published Jul 5, 2017. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: Oct 2, 2026. Content last changed: Oct 2, 2026.

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.